Skip to content
This GLP
Updated September 2026Read again in September

ARSYNL Rx review

Both figures were checked twice, a month apart, and the second reading is the one this page carries.

The verdict

Arsynl Rx publishes $219 a month for compounded semaglutide and $269 for tirzepatide, both re-read in September 2026, and the September reading is the one a buyer should carry into a comparison rather than any earlier quote.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
$219/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Arsynl Rx sells both molecules by injection, each with its own published monthly figure, and the fifty-dollar step between them is the ordinary shape of this market rather than anything unusual to this seller.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping, and the pages set out rates rather than describing the clinician behind them, so a reader learns what a month costs long before learning anything about who decides that a month is appropriate.

    Remote, and organized around the two product lines rather than around a course of care, with nothing published about what a clinician looks at between the first order and the fourth.

  2. What happens when the dose goes up?

    Consider the four months most buyers actually spend escalating. Nothing Arsynl Rx publishes says whether $219 is the figure at 0.25 milligrams or at 1.0, nor what it becomes at either end. A reader planning a winter of dose increases is planning against a number with no stated dose attached to it.

  3. What the price includes

    Six months of semaglutide at $219 is $1,314 and the tirzepatide line runs to $1,614 over the same span, and both totals hold only for a buyer whose dose stays where it started. The more useful fact is that these figures were read twice: a price this desk has watched move once is a price to confirm on the seller's own page on the day of ordering, including against this one.

  4. What it claims, and what it cites

    Both lines are compounded rather than manufactured, prepared by a pharmacy that is not named on any page here, and not reviewed by the FDA before dispensing in the way an approved product is.

Where it holds up, and where it does not

  • Strength: Both molecules carry a published figure
  • Strength: Figures re-read in September 2026
  • Strength: The tirzepatide premium is modest
  • Limitation: No milligram dose stated beside either
  • Limitation: Nothing published about dose pricing
  • Limitation: No state coverage list recorded
  • Limitation: No compounding pharmacy is named

What the evidence says about this kind of treatment

The assessment above is about ARSYNL Rx. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader who wants both molecules priced on one page and will confirm the figure on the day.
Wrong for
A reader who needs the dose behind a figure before treating it as comparable.

How ARSYNL Rx compares

SellerWho it suitsGo
Candor RxReaders who value a bill that does not move with the dose and will confirm the figure firstSee Candor Rx
AquaVita NextGenReaders who re-check a price on the day of ordering and will benefit from the lower oneSee AquaVita NextGen
Clume HealthReaders who want both molecules at one rate and will re-check the figure before payingSee Clume Health
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: GalaGenesis HealthGet Thin MDGlam HealthGo Vida PlenaGobyMeds

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

What do the two lines cost?
Semaglutide is $219 a month and tirzepatide is $269, both read in September 2026, which is the second reading this desk has taken of these figures.
Does either figure hold at a higher dose?
Arsynl Rx publishes nothing on that question, and an absence of a statement is not a promise that the figure holds, nor evidence that it climbs.
Why does the September date matter?
Because a figure this desk has re-read is a figure that could be re-read again, and any monthly number in this category is worth confirming on the seller's own page before the first charge.
Is ARSYNL Rx expensive compared with other GLP-1 telehealth sellers?
ARSYNL Rx publishes a starting figure of $219/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts ARSYNL Rx above the median. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Ruth AlvarezOutcomes writer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from ARSYNL Rx’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.